a clinical-stage biotechnology company focused on innovative therapies for serious diseases with significant unmet needs, announced the completion of dosing for the first cohort in its multi-center ...
A 42-year-old Black woman with no significant past medical history presents with blue-gray macules on her neck and upper chest that gradually developed over the past year.